SARS-CoV-2 (COVID-19) PCR
Coronavirus, 2019-nCoV, COVID-19, SARS, Novel coronavirus, SARS-CoV-2, COVID-19
Test Codes
EPIC: LAB1230607
Department
Molecular Pathology
Instructions
This test is indicated for routine priority testing for SARS-CoV-2 (COVID-19).
If STAT testing is needed for inpatient and ECs, order as “STAT” priority.
Specimen Collection Criteria
Collect: ONE of the following specimen types:
- Nasopharyngeal (NP) Swab: Collect using a Copan Universal Transport Media or BD Universal Viral Transport swab. Make sure the cap is tightly sealed.
- Oropharyngeal (OP) Swab: Collect using a Copan Universal Transport Media or BD Universal Viral Transport swab. Make sure the cap is tightly sealed.
- For collection, gently insert the oropharyngeal swab into the posterior pharynx and tonsillar areas. Rub the swab over both tonsillar pillars and posterior oropharynx while avoiding contact with the tongue, teeth and gums.
Physician Office/Draw Specimen Preparation
Maintain all specimens refrigerated (2-8°C or 36-46°F) prior to transport.
Preparation for Courier Transport
Transport: Nasopharyngeal swab in viral transport medium, refrigerated (2-8°C or 36-46°F).
Rejection Criteria
- Dry swabs.
- Specimens in non-sterile or leaking containers.
- Swabs other than those collected in viral transport media
- Specimens subjected to repeated freeze/thaw cycles.
- Contaminated media (e.g. yellow in color or contain black particles)
In-Lab Processing
Specimens are stable for 48 hours at room temperature (20-26°C or 68-78.8°F).
Specimens may also be refrigerated (2-8°C or 36-46°F) prior to testing.
Storage
Specimen Stability for Testing:
Room Temperature: 48 hours
Refrigerated (2-8°C or 36-46°F): 48hours
Frozen (-20°C/-4°F or below): 7 days
Specimen Storage in Department Prior to Disposal:
Frozen (-20°C/-4°F or below): 30 days
Laboratory
Royal Oak Molecular Pathology Laboratory
Performed
Sunday – Saturday.
Results available within 24-48 hours.
Reference Range
Not detected.
Test Methodology
Nucleic Acid Amplification. Roche cobas SARS-CoV-2 performed on the cobas 6800 (FDA-approved).
Interpretation
A “Detected” result indicates that SARS-CoV-2 RNA is present in the sample. Results should be clinically correlated in making a final diagnosis. This test does not discriminate between current and recent infections. This test is qualitative and should not be used as a test of cure.
A “Not Detected” result indicates that no SARS-CoV-2 RNA was present in the sample.
Clinical Utility
This assay aids in the detection of the SARS-CoV-2 (CoVID-19).This assay detects the pathogen's RNA and does not rely upon the presence of infectious virus or seroconversion.
Clinical Disease
SARS-CoV-2 is a positive-sense, single-stranded RNA virus that causes COVID-19. This virus can cause upper and lower respiratory tract infections. Symptoms of SARS-CoV-2 (CoVID-19) infection are similar to those of other respiratory viruses that occur seasonally in the winter and include:
- Fever
- Dry cough
- Fatigue
- Shortness of breath
| - Sore throat
- Chills
- Pneumonia
|
CPT Codes
87635
Contacts
Molecular Pathology Lab – RO
248-551-0073
Name: Molecular Pathology Lab – RO
Location:
Phone: 248-551-0073
Last Updated
8/28/2025
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.